| 1 | 124027-46-9 | CGS 22996 | CGS 22996 | C16H20N6O
| | |
| 2 | 477600-75-2 | 托法替尼 | Tofacitinib | C16H20N6O
| | |
| 3 | 1092578-46-5 | (3R,4S)-Tofacitinib | (3R,4S)-Tofacitinib | C16H20N6O
| 杂质对照品;对照品-杂质对照品;托法替尼杂质对照品;化学试剂、精细化学品、医药中间体、材料中间体 | |
| 4 | 1092578-43-2 | 托伐替尼杂质T | Tofacitinib impurity T | C16H20N6O
| 杂质对照品;托法替尼杂质 | 托法替尼杂质;杂质对照品 |
| 5 | 28226-14-4 | | 1-Triazene, 1,1'-(oxydi-4,1-phenylene)bis[3,3-dimethyl- | C16H20N6O
| | |
| 6 | | 4-AMINO-6-PIPERIDINO-N-(P-TOLYL)-1,3,5-TRIAZINE-2-CARBOXAMIDE | 4-AMINO-6-PIPERIDINO-N-(P-TOLYL)-1,3,5-TRIAZINE-2-CARBOXAMIDE | C16H20N6O
| | |
| 7 | | 1,8-DIAMINO-6-ETHOXY-3-PIPERIDIN-1-YL-2,7-NAPHTHYRIDINE-4-CARBONITRILE | 1,8-DIAMINO-6-ETHOXY-3-PIPERIDIN-1-YL-2,7-NAPHTHYRIDINE-4-CARBONITRILE | C16H20N6O
| | |
| 8 | 606104-09-0 | Piperazine, 1-(cyclobutylcarbonyl)-4-(1-phenyl-1H-tetrazol-5-yl)- (9CI) | Piperazine, 1-(cyclobutylcarbonyl)-4-(1-phenyl-1H-tetrazol-5-yl)- (9CI) | C16H20N6O
| | |
| 9 | | N-(4-METHYLPHENYL)-5-[(E)-PIPERIDIN-1-YLDIAZENYL]-1H-IMIDAZOLE-4-CARBOXAMIDE | N-(4-METHYLPHENYL)-5-[(E)-PIPERIDIN-1-YLDIAZENYL]-1H-IMIDAZOLE-4-CARBOXAMIDE | C16H20N6O
| | |
| 10 | | 8-Amino-5-methyl-3-(4-methyl-1-piperazinyl)-5H-pyridazino[3,4-b][1,4]benzoxazine | 8-Amino-5-methyl-3-(4-methyl-1-piperazinyl)-5H-pyridazino[3,4-b][1,4]benzoxazine | C16H20N6O
| | |
| 11 | | 4-[4-(3-METHOXYPROPYL)-5-METHYL-4H-1,2,4-TRIAZOL-3-YL]-1-PHENYL-1H-PYRAZOL-5-AMINE | 4-[4-(3-METHOXYPROPYL)-5-METHYL-4H-1,2,4-TRIAZOL-3-YL]-1-PHENYL-1H-PYRAZOL-5-AMINE | C16H20N6O
| | |
| 12 | 606108-10-5 | 3H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, N-(3-ethoxypropyl)-3-(phenylmethyl)- (9CI) | 3H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, N-(3-ethoxypropyl)-3-(phenylmethyl)- (9CI) | C16H20N6O
| | |
| 13 | 926076-01-9 | N-(1-cyano-1,2-dimethylpropyl)-2-[5-(4-methylphe nyl)-2H-1,2,3,4-tetrazol-2-yl]acetamide | N-(1-cyano-1,2-dimethylpropyl)-2-[5-(4-methylphe nyl)-2H-1,2,3,4-tetrazol-2-yl]acetamide | C16H20N6O
| | |
| 14 | 344418-92-4 | 托法替尼消旋体 | 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- | C16H20N6O
| 杂质对照品 | |
| 15 | 129909-52-0 | 5-METHYL-8-(2-MORPHOLINOETHYL)-7,8-DIHYDRO-6H-PYRAZOLO[1,5-A]PYRROLO[3,2-E]PYRIMIDINE-3-CARBONITRILE | 5-METHYL-8-(2-MORPHOLINOETHYL)-7,8-DIHYDRO-6H-PYRAZOLO[1,5-A]PYRROLO[3,2-E]PYRIMIDINE-3-CARBONITRILE | C16H20N6O
| | |
| 16 | 2374700-40-8 | 托法替尼杂质20 | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | C16H20N6O
| 076-托法替尼 | 076-托法替尼 |
| 17 | 2734856-31-4 | 托法替尼杂质26 | 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4S)-rel- | C16H20N6O
| | |